The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...
Safety and efficacy study of oral metronomic capecitabine in combination with pyrotinib for HER2-positive metastatic breast cancer: A phase II trial. Real world clinical outcomes of patients with HER2 ...
STOCKHOLM — Predictors of primary nonresponse and loss of response to anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease (IBD), including demographic, biochemical, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results